Cognitive impairment in the elderly: the need for a comprehensive approach

[1] Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018; 17:121. doi: 10.1186/s12933-018-0763-3. KaurR KaurM SinghJ Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies Cardiovasc Diabetol 2018 17 121 10.1186/s12933-018-0763-3 611798330170601 Open DOISearch in Google Scholar

[2] Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis. 2017; 1863:1037–45. PugazhenthiS QinL ReddyPH Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease Biochim Biophys Acta Mol Basis Dis 2017 1863 1037 45 10.1016/j.bbadis.2016.04.017534477127156888 Search in Google Scholar

[3] Diniz Pereira J, Gomes Fraga V, Morais Santos AL, Carvalho MDG, Caramelli P, Braga Gomes K. Alzheimer's disease and type 2 diabetes mellitus: a systematic review of proteomic studies. J Neurochem. 2021; 156:753–76. Diniz PereiraJ Gomes FragaV Morais SantosAL CarvalhoMDG CaramelliP Braga GomesK Alzheimer's disease and type 2 diabetes mellitus: a systematic review of proteomic studies J Neurochem 2021 156 753 76 10.1111/jnc.1516632909269 Search in Google Scholar

[4] Xuan K, Zhao T, Qu G, Liu H, Chen X, Sun Y. The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial. Neurol Sci. 2020; 41:1391–404. XuanK ZhaoT QuG LiuH ChenX SunY The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial Neurol Sci 2020 41 1391 404 10.1007/s10072-020-04243-631930449 Search in Google Scholar

[5] Olmastroni E, Molari G, De Beni N, Colpani O, Galimberti F, Gazzotti M, et al. Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol. 2021; zwab208. doi: 10.1093/eurjpc/zwab208 OlmastroniE MolariG De BeniN ColpaniO GalimbertiF GazzottiM Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies Eur J Prev Cardiol 2021 zwab208 10.1093/eurjpc/zwab208 34871380 Open DOISearch in Google Scholar

[6] Adhikari A, Tripathy S, Chuzi S, Peterson J, Stone NJ. Association between statin use and cognitive function: a systematic review of randomized clinical trials and observational studies. J Clin Lipidol. 2021; 15:22–32.e12. doi: 10.1016/j.jacl.2020.10.007 AdhikariA TripathyS ChuziS PetersonJ StoneNJ Association between statin use and cognitive function: a systematic review of randomized clinical trials and observational studies J Clin Lipidol 2021 15 22 32.e12 10.1016/j.jacl.2020.10.007 33189626 Open DOISearch in Google Scholar

[7] Sodero AO, Barrantes FJ. Pleiotropic effects of statins on brain cells. Biochim Biophys Acta Biomembr. 2020; 1862:183340. doi: 10.1016/j.bbamem.2020.183340 SoderoAO BarrantesFJ Pleiotropic effects of statins on brain cells Biochim Biophys Acta Biomembr 2020 1862 183340 10.1016/j.bbamem.2020.183340 32387399 Open DOISearch in Google Scholar

[8] Rahman SO, Hussain S, Alzahrani A, Akhtar M, Najmi AK. Effect of statins on amyloidosis in the rodent models of Alzheimer's disease: evidence from the preclinical meta-analysis. Brain Res. 2020; 1749:147115. doi: 10.1016/j.brainres.2020.147115 RahmanSO HussainS AlzahraniA AkhtarM NajmiAK Effect of statins on amyloidosis in the rodent models of Alzheimer's disease: evidence from the preclinical meta-analysis Brain Res 2020 1749 147115 10.1016/j.brainres.2020.147115 32918868 Open DOISearch in Google Scholar

[9] Zhou D, Liu H, Li C, Wang F, Shi Y, Liu L, et al. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice. Metab Brain Dis. 2016; 31:693–703. ZhouD LiuH LiC WangF ShiY LiuL Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice Metab Brain Dis 2016 31 693 703 10.1007/s11011-016-9803-426883430 Search in Google Scholar

[10] Del Ser T, Zea MA, Valentí M, Olazarán J, López-Álvarez J, Rebollo-Vázquez A, et al. Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people. J Psychopharmacol. 2019; 33:965–74. Del SerT ZeaMA ValentíM OlazaránJ López-ÁlvarezJ Rebollo-VázquezA Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people J Psychopharmacol 2019 33 965 74 10.1177/026988111985720631241413 Search in Google Scholar

[11] Kukula O, Günaydın C. Atorvastatin inhibits alloxan-induced memory and cognitive impairment. Asian Biomed (Res Rev News). 2022; 15:71–78. KukulaO GünaydınC Atorvastatin inhibits alloxan-induced memory and cognitive impairment Asian Biomed (Res Rev News) 2022 15 71 78 10.2478/abm-2022-0009 Search in Google Scholar

[12] Tisher A, Salardini A. A comprehensive update on treatment of dementia. Semin Neurol. 2019; 39:167–78. TisherA SalardiniA A comprehensive update on treatment of dementia Semin Neurol 2019 39 167 78 10.1055/s-0039-168340830925610 Search in Google Scholar

[13] Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening. J Neurol. 2021; 268:1615–22. ZhuangL YangY GaoJ Cognitive assessment tools for mild cognitive impairment screening J Neurol 2021 268 1615 22 10.1007/s00415-019-09506-731414193 Search in Google Scholar